Cargando…
Azasugar inhibitors as pharmacological chaperones for Krabbe disease
Krabbe disease is a devastating neurodegenerative disorder characterized by rapid demyelination of nerve fibers. This disease is caused by defects in the lysosomal enzyme β-galactocerebrosidase (GALC), which hydrolyzes the terminal galactose from glycosphingolipids. These lipids are essential compon...
Autores principales: | Hill, Chris H., Viuff, Agnete H., Spratley, Samantha J., Salamone, Stéphane, Christensen, Stig H., Read, Randy J., Moriarty, Nigel W., Jensen, Henrik H., Deane, Janet E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445328/ https://www.ncbi.nlm.nih.gov/pubmed/26029356 http://dx.doi.org/10.1039/c5sc00754b |
Ejemplares similares
-
New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
por: Spratley, Samantha J., et al.
Publicado: (2016) -
Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants
por: Spratley, Samantha J., et al.
Publicado: (2016) -
Comparative genomic analysis of azasugar biosynthesis
por: Beal, Hailey E., et al.
Publicado: (2021) -
Exploring endoperoxides as a new entry for the synthesis of branched azasugars
por: Domeyer, Svenja, et al.
Publicado: (2017) -
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases
por: Sylte, Ingebrigt, et al.
Publicado: (2018)